scholarly journals Achalasia cardia

2021 ◽  
Author(s):  
Henry Knipe ◽  
Dijendra Biswas
Keyword(s):  
Achalasia Cardia

A rare case of duodenal cancer with achalasia cardia

2019 ◽  
Vol 22 (2) ◽  
pp. 32-34
Author(s):  
Kartikesh Mishra
Keyword(s):  
Case Report ◽  
Rare Case ◽  
Similar Case ◽  
Barium Meal ◽  
Duodenal Adenocarcinoma ◽  
Gastrointestinal Malignancies ◽  
Achalasia Cardia ◽  
Proliferative Growth ◽  
History Of ◽  
Duodenal Carcinoma

Duodenal adenocarcinoma constitutes 0.4% of gastrointestinal malignancies. Achalasia incidence rate is 0.5-1.2 per 100000. The combination is rare. This is a report of a 68-year-old male from Nepal with history of five years abdominal pain, dysphasia and weight loss. Duodenoscopy could confirm ulcero-proliferative growth at D1-D2. Barium meal depicted features of achalasia cardia. No similar case report suggests that occurrence of duodenal carcinoma and achalasia cardia is merely co- incidental. Discussion: No similar case report suggests that occurrence of duodenal carcinoma and achalasia cardia is merely co- incidental. Consent: Informed consent was obtained from the patient for publication of this case report .

scholarly journals Achalasia Cardia: A Mimicker of Pulmonary Tuberculosis in a High-Burden Setting

2020 ◽  
Author(s):  
Pratibha Sharma ◽  
Ranganath T. Ganga
Keyword(s):  
South Africa ◽  
Adverse Effects ◽  
Respiratory Symptoms ◽  
Antitubercular Drugs ◽  
Achalasia Cardia ◽  
High Burden ◽  
Antitubercular Treatment ◽  
Common Diagnosis ◽  
National Tuberculosis ◽  
Long Time

AbstractBRICS (Brazil, Russia, India, China, and South Africa) countries account for more than two-thirds of the global tuberculosis burden. Tuberculosis is a common diagnosis in patients presenting with chronic respiratory symptoms in these high-burden countries, which results in other diseases being missed easily. The national tuberculosis elimination program encourages to start antitubercular treatment on a clinical basis even without any confirmatory evidence. This has resulted in missing many nontuberculosis cases and unnecessarily exposing to adverse effects of antitubercular drugs. Here we report one such instance where achalasia cardia was missed for a long time.

Pulmonary Actinomycosis as the Masquerader of Pulmonary Tuberculosis in a Young Male With Achalasia Cardia

2011 ◽  
Vol 19 (4) ◽  
pp. 291-292
Author(s):  
Abdul Majid Wani ◽  
Najah Rashid Zayyani ◽  
Waleed Mohd Hussain ◽  
Zeyad S. Alharbi ◽  
Amer M. Khoujah ◽  
...  
Keyword(s):  
Pulmonary Tuberculosis ◽  
Young Male ◽  
Achalasia Cardia ◽  
Pulmonary Actinomycosis

scholarly journals COMPREHENSIVE ESTIMATION OF THE RESULTS OF ESOPHAGO-CARDIOFUNDOPLASTICS IN STAGE III-IV ACHALASIA CARDIA

2018 ◽  
pp. 94-101
Author(s):  
V.V. Anishchenko ◽  
◽  
Yu.M. Kovgan ◽  
A.G. Nalbandyan ◽  
D.A. Kim ◽  
...  
Keyword(s):  
Stage Iii ◽  
Achalasia Cardia

scholarly journals Successful pneumatic dilatation of achalasia cardia in a preschool child

2009 ◽  
Vol 32 (4) ◽  
pp. 111
Author(s):  
K A W Karunasekera ◽  
R Fernando ◽  
A C Jayasinghe ◽  
S Rajendran
Keyword(s):  
Preschool Child ◽  
Pneumatic Dilatation ◽  
Achalasia Cardia

scholarly journals Endoscopic Evaluation of Achalasia Cardia

1970 ◽  
Vol 20 (2) ◽  
Author(s):  
Md Abdul Ahad
Keyword(s):  
Endoscopic Evaluation ◽  
Achalasia Cardia

doi: 10.3329/taj.v20i2.3066TAJ December 2007; Volume 20 Number 2

Retrograde Myotomy as an Alternative to Antegrade Myotomy in Peroral Endoscopic Myotomy (POEM) for Achalasia Cardia – Is It Better?

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Harshal S. Mandavdhare ◽  
Jayanta Samanta ◽  
Anudeep Jafra ◽  
Rajeev Chauhan ◽  
Harjeet Singh ◽  
...  
Keyword(s):  
Peroral Endoscopic Myotomy ◽  
Achalasia Cardia ◽  
Endoscopic Myotomy

Outcome of Pneumatic Balloon Dilatation in Achalasia Cardia

2021 ◽  
Vol 10 (1) ◽  
pp. 8-13
Author(s):  
Shankar Baral ◽  
Bidhan NIdhi Paudel ◽  
Ajit Khanal ◽  
Jiwan Thapa ◽  
Bhuwneshwer Yadhav ◽  
...  
Keyword(s):  
Observational Study ◽  
Lower Esophageal Sphincter ◽  
Poor Response ◽  
Lower Esophageal Sphincter Pressure ◽  
Pneumatic Dilatation ◽  
Response To Treatment ◽  
Sphincter Pressure ◽  
Achalasia Cardia ◽  
Type Iii ◽  
Esophageal Sphincter

Background: Achalasia Cardia is a rare esophageal motility disorder. Among various treatment options, Pneumatic Dilatation (PD) is the most widely used and cost effective modality till date. This is the first observational study aiming to evaluate the short term response and complications of PD for Achalasia Cardia in Nepal. Methods: This prospective observational study was conducted between 28th Jan 2020 to 27th Jan 2021. It included 39 patients with Achalasia Cardia diagnosed by clinical presentation, esophagoscopy, barium esophagogram and high resolution manometry. Two patients of Type III achalasia were excluded from study. Thirty seven patients underwent pneumatic dilatation with 30 mm Rigiflex balloon (Boston Scientific, USA) for a duration of 1 minute. Response was assessed by Eckardts score at 3 and 6 months. Result: Among 39 cases (mean age= 39.03±15.017 years, 59% men), commonest was Type II Achalasia (71.8%) followed by Type I (23.1%) and Type III (5.1%). Dysphagia was present in all patients (100%), followed by weight loss (84.6%), regurgitation (79.5%) and chest pain (35.9%). Mean basal Eckardts score and Lower Esophageal Sphincter pressure of the study population was 7.81±1.24 and 24.40±6.83 respectively. Response to pneumatic dilatation was 89.2%. Eckardts score changed significantly from7.81±1.24 to 1.03±1.82 at 6 months (p<0.001). None of the patients had major complications. Younger age (23±6.377 years) had poor response to treatment, while predilatation Lower Esophageal Sphincter pressure, gender and type of achalasia did not affect the treatment outcome. Conclusion: PD is safe and effective treatment modality for Achalasia. Younger patients have poor response to treatment with Pneumatic Dilatation.  

Sign in / Sign up

Export Citation Format

Share Document